YU40293A - Derivati hidroksamične kiseline - Google Patents
Derivati hidroksamične kiselineInfo
- Publication number
- YU40293A YU40293A YU40293A YU40293A YU40293A YU 40293 A YU40293 A YU 40293A YU 40293 A YU40293 A YU 40293A YU 40293 A YU40293 A YU 40293A YU 40293 A YU40293 A YU 40293A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- alkyl
- atoms
- group
- atom
- amino acid
- Prior art date
Links
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001371 alpha-amino acids Chemical class 0.000 abstract 2
- 235000008206 alpha-amino acids Nutrition 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000524 functional group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 201000008482 osteoarthritis Diseases 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- -1 benzyloxyamino compound Chemical class 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000009545 invasion Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 201000003068 rheumatic fever Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/22—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929213473A GB9213473D0 (en) | 1992-06-25 | 1992-06-25 | Hydroxamic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU40293A true YU40293A (sh) | 1997-07-31 |
Family
ID=10717706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU40293A YU40293A (sh) | 1992-06-25 | 1993-06-09 | Derivati hidroksamične kiseline |
Country Status (12)
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601368D0 (en) * | 1986-01-21 | 1986-02-26 | Ici America Inc | Hydroxamic acids |
| US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
-
1992
- 1992-06-25 GB GB929213473A patent/GB9213473D0/en active Pending
-
1993
- 1993-04-05 GB GB939307081A patent/GB9307081D0/en active Pending
- 1993-06-02 TW TW082104397A patent/TW279157B/zh active
- 1993-06-09 YU YU40293A patent/YU40293A/sh unknown
- 1993-06-10 SI SI9300313A patent/SI9300313A/sl unknown
- 1993-06-16 HR HR9213473.3A patent/HRP930980A2/xx not_active Application Discontinuation
- 1993-06-18 ZA ZA934398A patent/ZA934398B/xx unknown
- 1993-06-18 MX MX9303672A patent/MX9303672A/es not_active IP Right Cessation
- 1993-06-23 MY MYPI93001217A patent/MY134743A/en unknown
- 1993-06-24 PL PL93299465A patent/PL299465A1/xx unknown
- 1993-06-24 BR BR9302642A patent/BR9302642A/pt not_active Application Discontinuation
- 1993-06-24 KR KR1019930011598A patent/KR100311556B1/ko not_active Expired - Fee Related
- 1993-06-24 UY UY23606A patent/UY23606A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100311556B1 (ko) | 2002-02-19 |
| ZA934398B (en) | 1993-12-27 |
| KR940005556A (ko) | 1994-03-21 |
| PL299465A1 (en) | 1994-03-07 |
| GB9307081D0 (en) | 1993-05-26 |
| MY134743A (en) | 2007-12-31 |
| BR9302642A (pt) | 1994-01-11 |
| TW279157B (enrdf_load_stackoverflow) | 1996-06-21 |
| GB9213473D0 (en) | 1992-08-12 |
| MX9303672A (es) | 1994-01-31 |
| UY23606A1 (es) | 1993-12-15 |
| HRP930980A2 (en) | 1997-02-28 |
| SI9300313A (sl) | 1993-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE162514T1 (de) | Hydroxamsäurederivate und deren pharmazeutische zusammensetzungen | |
| AR036873A1 (es) | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento | |
| NO932117L (no) | Hydroksaminsyrederivater | |
| AR004495A1 (es) | Compuestos derivados de acido amino sustituido arilo y heteroarilo carboxilico; composicion farmaceutica que los contiene; uso de los compuestos; proceso para preparar dichos compuestos y compuestos utiles como material de partida. | |
| AR061273A1 (es) | Terapia que utiliza inhibidores de citocina | |
| AR037233A1 (es) | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento | |
| HUP0401819A2 (hu) | Proteinkináz inhibitorokként alkalmazható pirazolvegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| MY117557A (en) | 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives | |
| HUP0103511A2 (hu) | Oxazolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására | |
| AR058769A1 (es) | Inhibidores de peptidil-deformilasa(pdf),utiles para el tratamiento de la tuberculosis y composiciones farmaceuticas que los contienen. | |
| ATE114670T1 (de) | Phenylamidinderivate als plättchenaggregationsinhibitoren. | |
| TW375609B (en) | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present | |
| DK0753301T3 (da) | Kombination af et benzimidazol med angiotensin-II-antagonistisk aktivitet med et diuretika | |
| MY110517A (en) | Indoline derivatives carrying an amide functional group their preparation and the pharmaceutical compositions in which they are present. | |
| ATE256663T1 (de) | Anthranilsäure-derivate als modulatoren der multidrug resistenz. | |
| MX2010000658A (es) | Derivados de pirimidina 934. | |
| ATE450499T1 (de) | Durch enzyme spaltbare prodrugs von substituierten stickstoff-lost-derivaten | |
| ATE170845T1 (de) | Plättchenaggregationsinhibitoren | |
| RS50577B (sr) | Novi azabiciklični derivati, njihov postupak izrade i farmaceutske smeše koje ih sadrže | |
| JP2008534541A5 (enrdf_load_stackoverflow) | ||
| TW200745104A (en) | Multikinase inhibitor | |
| ATE72431T1 (de) | 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren. | |
| KR880007461A (ko) | 헤테로 사이클-치환 디포스포네이트화합물 및 이의 약제학적 조성물 | |
| DK0659193T3 (da) | Blodpladeaggregationsinhibitorer | |
| YU40293A (sh) | Derivati hidroksamične kiseline |